Randomized phase II trial of maintenance autologous tumor cell vaccine (FANG™) following clinical complete response (cCR) in stage III/IV ovarian cancer: Preliminary results
Saved in:
Published in: | Gynecologic oncology Vol. 137; pp. 2 - 3 |
---|---|
Main Authors: | , , , , , , , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
Elsevier Inc
01-04-2015
|
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
ISSN: | 0090-8258 1095-6859 |
---|---|
DOI: | 10.1016/j.ygyno.2015.01.003 |